NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
02 April 2025
| Name: | REWARDLE HOLDINGS LIMITED (RXH) |
| ISIN: | AU000000RXH4 |
| Date of Listing: | 07 October 2014 |
Stock Exchange Status: (updated daily)
This entity is currently suspended from quotation on the Australian Securities Exchange and its securities cannot be traded on-market.Legal Status: (updated monthly)
ACN: 168 751 746ABN: 37 168 751 746
Registration Date: 25 March 2014
Capital Gains Tax (CGT) Status: (updated at least quarterly)
The securities in this entity may be suspended from quotation for reasons unrelated to its financial health or we have made the assessment that the securities still have value. If you are seeking to crystallise a capital loss on your securities, you should firstly consider whether your company is the subject of either a takeover or that you will be able to sell your securities on-market for value if the entity regains quotation. Entities in this category are reviewed monthly and it is possible that our assessment may change. If you are seeking to crystallise a capital loss on your securities, that process can be easily and quickly initiated at our online Worthless Shares facility here: https://www.delisted.com.au/sell-worthless-and-other-securities/.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
Automic Registry Pty Ltd
Level 5, 191 ST GEORGES TERRACE PERTH WA 6000
Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
RegistryWebsite RegistryEmail
Expand this box to read and print
The company lodges its Half Yearly Report and Accounts from December 2023. | 19/02/2025 |
The company releases a response to an ASX query letter. | 12/02/2025 |
The company lodges its Quarterly Activities and Quarterly Appendix 4C Cash Flow Report. | 31/01/2025 |
The entities suspended for over three months failed periodic reports, the oldest outstanding report deadline, and their 2 year deadline for trading plans. If not met, they will be removed from the official list, usually after the first trading day. | 22/01/2025 |
The company will release 2,600,000 fully paid ordinary shares from voluntary escrow on 26 December 2024, in connection with the acquisition of 100% of Sub11 Pty Ltd shares. | 19/12/2024 |
The company lodges its Quarterly Activities Report. | 31/10/2024 |
The company lodges its Quarterly Appendix 4C Cash Flow Report. | 31/10/2024 |
ASX releases a notice regarding long-term suspended entities. The company's securities have been suspended for more than 3 months. If an entity does not meet the 1 or 2 year deadlines, it will be removed from the official list. The removal will usually take effect from the open of trading on the first trading day after the deadline date. | 18/10/2024 |
The company has suspended trading in its listed securities due to inability to lodge the FY23 accounts by 29th September 2023. The suspension will continue until the outstanding accounts are settled. The company has released its Audited FY23 Annual Report, which will aid in preparing the interim and preliminary reports. The company is working with its auditor to complete outstanding accounts. | 02/09/2024 |
The company lodges its appendix 4g. | 02/09/2024 |
The company lodges its annual report to shareholders for 2023. | 30/08/2024 |
The company lodges its Quarterly Appendix 4C Cash Flow Report and Quarterly Activities Report. | 01/08/2024 |
The securities of the company have been suspended for more than three months. If an entity does not meet the 1 or 2 year deadlines, it will be removed from the official list. The removal will usually take effect from the open of trading on the first trading day after the deadline date. | 10/07/2024 |
The Company is currently working with its auditor to complete the audit of the Company's FY23 Annual Report, which in turn facilitates the opening balances to be used in preparation of the Company's outstanding 31 December 2023 Interim Report. While it was initially expected that the audit and audit review of the outstanding accounts could be completed prior to 30 June 2024, the work is ongoing. The Company is working with its auditor to complete the audit and audit review of the outstanding accounts as soon as practicable and will provide further updates as appropriate. | 01/07/2024 |
The company releases an update on trading suspension. The Company was unable to lodge its FY23 accounts by 29th September 2023, leading to suspended trading in its listed securities. The delay was due to auditors determining audited accounts were required for CloudHolter Pty Ltd, a private company not controlled by the Company. The Company requested CH to undertake an audit and work with CH and its auditors. However, CH had strategic and technical considerations to work through. The Company is now working with CH to schedule the completion of the audit and audit review of outstanding accounts, with the outstanding accounts expected to be lodged before 30 June 2024. The Company is working with auditors to schedule the audit and review of outstanding accounts as soon as possible. | 03/05/2024 |
The company releases its Quarterly Appendix 4C Cash Flow Report. | 30/04/2024 |
The company releases its Quarterly Activities Report. | 30/04/2024 |
The company lodges its Appendix 4C Cash Flow Report. | 01/02/2024 |
The company lodges its Quarterly Activities Report. | 01/02/2024 |
The company releases a notice of application for quotation of securities. | 19/12/2023 |
The company releases a notice of proposed issue of securities. | 18/12/2023 |
Acquisition of Sub11, a Fintech sector publisher and investor engagement consultancy. Sub11 will leverage Rewardle's recent acquisition of the distribution rights to the Upstreet fund. Sub11 valuation of ~$75,000 to be paid via issue of 2,600,000 RXH Fully Paid Ordinary Shares. | 18/12/2023 |
$1.5m investment to acquire controlling stake in meal kit partner Pepper Leaf. Majority of investment retained as working capital via commercialloan arrangement. Consolidates grocery volume and expands grocery service offering. | 08/11/2023 |
The company lodges its Quarterly Activities Report. | 01/11/2023 |
The company lodges its Appendix 4C Cash Flow Report. | 01/11/2023 |
Rewardle has completed the acquisition of the distribution rights for the Upstreetfund for $30,000 (once off) and ~$15,000/month (ongoing operating cost), which will provide the Rewardle Platform with micro-investing capability. The transaction substantially reduces the cost and accelerates the speed to market of extending the Rewardle Platform to include micro-investing capability. Initial implementation expected to be live in the next 2-3 weeks withphased releases of additional features and functionality to follow in coming months. | 10/10/2023 |
The securities of the entity will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Monday, 2 October 2023, for not lodging the relevant periodic report by the due date. If the report is lodged between the closure of the market announcements office on Friday, 29 September 2023, and the imposition of the suspension, the entity's securities will normally be reinstated to quotation on the next trading day after the suspension is imposed. | 02/10/2023 |
The suspension of trading in the securities of Rewardle Holdings Limited will be lifted from the commencement of trading on Tuesday, 2 May 2023 following lodgement of its quarterly activity report and Appendix 4C for the quarter ended 31 March 2023. | 02/05/2023 |
The securities of the entity will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Monday, 1 May 2023, for not lodging the relevant periodic report by the due date. If the report is lodged between the closure of the market announcements office on Friday, 28 April 2023, and the imposition of the suspension, the entity's securities will normally be reinstated to quotation on the next trading day after the suspension is imposed. | 01/05/2023 |
The company lodges its Quarterly Activities Report. | 01/05/2023 |
The company lodges its Appendix 4C Cash Flow Report. | 01/05/2023 |
The suspension of trading in the securities of Rewardle Holdings Limited will be lifted immediately, following the release by RXH of an announcement regarding a further announcement in relation to the application of Listing Rule 11.1 to the transaction, the subject of the announcement released on 2 August 2021, titled "MedTech Growth Services Agreement". | 12/08/2021 |
Listing Rule 11.1 does not apply to the Transaction which included the execution of a binding Terms Sheet to provide services to Cardiac Rhythm Diagnostics, a fast-growing MedTech business that is developing a disruptive, technology enabled cardiac diagnostics service for local GPs. | 12/08/2021 |
The securities of Rewardle Holdings Limited will be suspended from quotation from the commencement of trading on Friday, 6 August 2021 under Listing under Listing Rule 17.2, at the request of RXH, pending the release of a further announcement in relation to the application of Listing Rule 11.1 to the transaction, the subject of the announcement released on 2 August 2021, titled "MedTech Growth Services Agreement". | 06/08/2021 |
The suspension of trading in the securities of Rewardle Holdings Limited (the "Company ") will be lifted immediately, following receipt of an announcement regarding a capital raising of $5 million. Security Code: RXH | 27/03/2015 |
The securities of Rewardle Holdings Limited (the "Company") will be suspended from official quotation immediately at the request of the Company, pending the release of an announcement. Security Code: RXH | 26/03/2015 |
The company lodges its Half Yearly Report and Accounts from December 2023. | 19/02/2025 |
The company releases a response to an ASX query letter. | 12/02/2025 |
The company lodges its Quarterly Activities and Quarterly Appendix 4C Cash Flow Report. | 31/01/2025 |
The entities suspended for over three months failed periodic reports, the oldest outstanding report deadline, and their 2 year deadline for trading plans. If not met, they will be removed from the official list, usually after the first trading day. | 22/01/2025 |
The company will release 2,600,000 fully paid ordinary shares from voluntary escrow on 26 December 2024, in connection with the acquisition of 100% of Sub11 Pty Ltd shares. | 19/12/2024 |
The company lodges its Quarterly Activities Report. | 31/10/2024 |
The company lodges its Quarterly Appendix 4C Cash Flow Report. | 31/10/2024 |
ASX releases a notice regarding long-term suspended entities. The company's securities have been suspended for more than 3 months. If an entity does not meet the 1 or 2 year deadlines, it will be removed from the official list. The removal will usually take effect from the open of trading on the first trading day after the deadline date. | 18/10/2024 |
The company has suspended trading in its listed securities due to inability to lodge the FY23 accounts by 29th September 2023. The suspension will continue until the outstanding accounts are settled. The company has released its Audited FY23 Annual Report, which will aid in preparing the interim and preliminary reports. The company is working with its auditor to complete outstanding accounts. | 02/09/2024 |
The company lodges its appendix 4g. | 02/09/2024 |
The company lodges its annual report to shareholders for 2023. | 30/08/2024 |
The company lodges its Quarterly Appendix 4C Cash Flow Report and Quarterly Activities Report. | 01/08/2024 |
The securities of the company have been suspended for more than three months. If an entity does not meet the 1 or 2 year deadlines, it will be removed from the official list. The removal will usually take effect from the open of trading on the first trading day after the deadline date. | 10/07/2024 |
The Company is currently working with its auditor to complete the audit of the Company's FY23 Annual Report, which in turn facilitates the opening balances to be used in preparation of the Company's outstanding 31 December 2023 Interim Report. While it was initially expected that the audit and audit review of the outstanding accounts could be completed prior to 30 June 2024, the work is ongoing. The Company is working with its auditor to complete the audit and audit review of the outstanding accounts as soon as practicable and will provide further updates as appropriate. | 01/07/2024 |
The company releases an update on trading suspension. The Company was unable to lodge its FY23 accounts by 29th September 2023, leading to suspended trading in its listed securities. The delay was due to auditors determining audited accounts were required for CloudHolter Pty Ltd, a private company not controlled by the Company. The Company requested CH to undertake an audit and work with CH and its auditors. However, CH had strategic and technical considerations to work through. The Company is now working with CH to schedule the completion of the audit and audit review of outstanding accounts, with the outstanding accounts expected to be lodged before 30 June 2024. The Company is working with auditors to schedule the audit and review of outstanding accounts as soon as possible. | 03/05/2024 |
The company releases its Quarterly Appendix 4C Cash Flow Report. | 30/04/2024 |
The company releases its Quarterly Activities Report. | 30/04/2024 |
The company lodges its Appendix 4C Cash Flow Report. | 01/02/2024 |
The company lodges its Quarterly Activities Report. | 01/02/2024 |
The company releases a notice of application for quotation of securities. | 19/12/2023 |
The company releases a notice of proposed issue of securities. | 18/12/2023 |
Acquisition of Sub11, a Fintech sector publisher and investor engagement consultancy. Sub11 will leverage Rewardle's recent acquisition of the distribution rights to the Upstreet fund. Sub11 valuation of ~$75,000 to be paid via issue of 2,600,000 RXH Fully Paid Ordinary Shares. | 18/12/2023 |
$1.5m investment to acquire controlling stake in meal kit partner Pepper Leaf. Majority of investment retained as working capital via commercialloan arrangement. Consolidates grocery volume and expands grocery service offering. | 08/11/2023 |
The company lodges its Quarterly Activities Report. | 01/11/2023 |
The company lodges its Appendix 4C Cash Flow Report. | 01/11/2023 |
Rewardle has completed the acquisition of the distribution rights for the Upstreetfund for $30,000 (once off) and ~$15,000/month (ongoing operating cost), which will provide the Rewardle Platform with micro-investing capability. The transaction substantially reduces the cost and accelerates the speed to market of extending the Rewardle Platform to include micro-investing capability. Initial implementation expected to be live in the next 2-3 weeks withphased releases of additional features and functionality to follow in coming months. | 10/10/2023 |
The securities of the entity will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Monday, 2 October 2023, for not lodging the relevant periodic report by the due date. If the report is lodged between the closure of the market announcements office on Friday, 29 September 2023, and the imposition of the suspension, the entity's securities will normally be reinstated to quotation on the next trading day after the suspension is imposed. | 02/10/2023 |
The suspension of trading in the securities of Rewardle Holdings Limited will be lifted from the commencement of trading on Tuesday, 2 May 2023 following lodgement of its quarterly activity report and Appendix 4C for the quarter ended 31 March 2023. | 02/05/2023 |
The securities of the entity will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Monday, 1 May 2023, for not lodging the relevant periodic report by the due date. If the report is lodged between the closure of the market announcements office on Friday, 28 April 2023, and the imposition of the suspension, the entity's securities will normally be reinstated to quotation on the next trading day after the suspension is imposed. | 01/05/2023 |
The company lodges its Quarterly Activities Report. | 01/05/2023 |
The company lodges its Appendix 4C Cash Flow Report. | 01/05/2023 |
The suspension of trading in the securities of Rewardle Holdings Limited will be lifted immediately, following the release by RXH of an announcement regarding a further announcement in relation to the application of Listing Rule 11.1 to the transaction, the subject of the announcement released on 2 August 2021, titled "MedTech Growth Services Agreement". | 12/08/2021 |
Listing Rule 11.1 does not apply to the Transaction which included the execution of a binding Terms Sheet to provide services to Cardiac Rhythm Diagnostics, a fast-growing MedTech business that is developing a disruptive, technology enabled cardiac diagnostics service for local GPs. | 12/08/2021 |
The securities of Rewardle Holdings Limited will be suspended from quotation from the commencement of trading on Friday, 6 August 2021 under Listing under Listing Rule 17.2, at the request of RXH, pending the release of a further announcement in relation to the application of Listing Rule 11.1 to the transaction, the subject of the announcement released on 2 August 2021, titled "MedTech Growth Services Agreement". | 06/08/2021 |
The suspension of trading in the securities of Rewardle Holdings Limited (the "Company ") will be lifted immediately, following receipt of an announcement regarding a capital raising of $5 million. Security Code: RXH | 27/03/2015 |
The securities of Rewardle Holdings Limited (the "Company") will be suspended from official quotation immediately at the request of the Company, pending the release of an announcement. Security Code: RXH | 26/03/2015 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 15/05/2023 | Ruwan Weerasooriya | 364,667 | $0.034 | $12,399 |
| 15/05/2023 | Rodney House | 267,033 | $0.037 | $9,866 |
| 09/05/2023 | Rodney House | 298,572 | $0.034 | $10,000 |
| 09/05/2023 | Ruwan Weerasooriya | 431,500 | $0.033 | $14,126 |
| 09/05/2023 | David Niall | 720,000 | $0.033 | $23,700 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Ruwan Weerasooriya | Executive Chairman, Managing Director | 07/10/2014 |
| Rodney House | Non Exec Director | 03/01/2019 |
| David Niall | Executive Director | 30/05/2017 |
| Nicholas Day | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Peter Pawlowitsch | Independent Director | 30/05/2017 | 03/01/2019 |
| Jack Matthews | Non Exec Chairman | 07/10/2014 | 30/05/2017 |
| Brandon Munro | Non Exec Director | 07/10/2014 | 30/05/2017 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2025 Investogain Pty Limited. All rights reserved.
